Florian A. Lempp

7.7k total citations · 1 hit paper
30 papers, 2.0k citations indexed

About

Florian A. Lempp is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Florian A. Lempp has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 24 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Florian A. Lempp's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (24 papers) and Liver Disease Diagnosis and Treatment (12 papers). Florian A. Lempp is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (24 papers) and Liver Disease Diagnosis and Treatment (12 papers). Florian A. Lempp collaborates with scholars based in Germany, France and United States. Florian A. Lempp's co-authors include Stephan Urban, Yi Ni, Christina Kaufman, Shirin Nkongolo, Stefan Mehrle, Jan Stindt, Maria Fälth, Holger Sültmann, Michael Nassal and Ralf Kubitz and has published in prestigious journals such as Nature Communications, Gastroenterology and Hepatology.

In The Last Decade

Florian A. Lempp

28 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes

2013 602 citations Yi Ni, Florian A. Lempp et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florian A. Lempp Germany	20	1.8k	1.4k	308	271	254	30	2.0k
Chen Pan China	11	1.6k 0.9×	1.2k 0.9×	314 1.0×	353 1.3×	188 0.7×	32	2.0k
Lena Allweiss Germany	25	2.5k 1.4×	2.1k 1.5×	369 1.2×	387 1.4×	166 0.7×	66	2.8k
Thomas Tu Australia	21	1.3k 0.8×	1.1k 0.8×	148 0.5×	271 1.0×	138 0.5×	61	1.6k
G. Raffa Italy	17	1.8k 1.0×	1.5k 1.0×	186 0.6×	375 1.4×	107 0.4×	30	2.0k
Yonghe Qi China	15	2.3k 1.3×	1.7k 1.2×	631 2.0×	560 2.1×	293 1.2×	18	3.0k
Julie Lucifora France	27	1.8k 1.0×	1.4k 1.0×	388 1.3×	434 1.6×	115 0.5×	63	2.3k
Dongping Xu China	22	1.4k 0.8×	1.2k 0.9×	219 0.7×	152 0.6×	79 0.3×	66	1.7k
Michael J. McGarvey United Kingdom	18	1.6k 0.9×	1.4k 1.0×	250 0.8×	325 1.2×	61 0.2×	33	1.9k
Jeffry Saputelli United States	16	1.7k 1.0×	1.3k 0.9×	479 1.6×	216 0.8×	90 0.4×	17	1.8k
Teresa I. Ng United States	26	1.4k 0.8×	1.1k 0.8×	661 2.1×	230 0.8×	111 0.4×	59	2.0k

Countries citing papers authored by Florian A. Lempp

Since Specialization

Citations

This map shows the geographic impact of Florian A. Lempp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian A. Lempp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian A. Lempp more than expected).

Fields of papers citing papers by Florian A. Lempp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian A. Lempp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian A. Lempp. The network helps show where Florian A. Lempp may publish in the future.

Co-authorship network of co-authors of Florian A. Lempp

This figure shows the co-authorship network connecting the top 25 collaborators of Florian A. Lempp. A scholar is included among the top collaborators of Florian A. Lempp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian A. Lempp. Florian A. Lempp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Jiayi, Hannah Kaiser, Eduardo Melani Rocha, et al.. (2025). Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection. JHEP Reports. 7(6). 101400–101400. 1 indexed citations

Qu, Bingqian, Florian A. Lempp, Zhenfeng Zhang, et al.. (2024). An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes. EMBO Reports. 25(10). 4311–4336.

Maher, M. Cyrus, István Bartha, Steven Weaver, et al.. (2022). Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Science Translational Medicine. 14(633). eabk3445–eabk3445. 99 indexed citations

Zhang, Zhenfeng, Yi Ni, Florian A. Lempp, et al.. (2022). Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread. Journal of Hepatology. 77(4). 957–966. 41 indexed citations

Chi, Xiumei, Florian A. Lempp, Bingqian Qu, et al.. (2021). HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection. Viruses. 13(9). 1799–1799. 19 indexed citations

Wang, Wenshi, Florian A. Lempp, Lisa Walter, et al.. (2021). Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates. Journal of Hepatology. 75(2). 311–323. 35 indexed citations

Angleró-Rodríguez, Yesseinia, Florian A. Lempp, Abigail Liebow, et al.. (2020). In vitro and in vivo characterization of VIR-2218, an investigational RNAi therapeutic targeting hepatitis B virus. Journal of Hepatology. 73. S865–S865. 2 indexed citations

Ni, Yi, et al.. (2019). Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus. Scientific Reports. 9(1). 10021–10021. 24 indexed citations

Lempp, Florian A., et al.. (2019). Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation. Nature Communications. 10(1). 2265–2265. 41 indexed citations

10.

Lempp, Florian A., Shirin Nkongolo, Paul Schnitzler, et al.. (2019). PS-053-A rapid point-of-care device for the diagnosis of hepatitis delta virus infection. Journal of Hepatology. 70(1). e32–e33. 2 indexed citations

11.

Nkongolo, Shirin, Lea Nußbaum, Florian A. Lempp, et al.. (2019). The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA. Antiviral Research. 168. 146–155. 17 indexed citations

12.

Mutz, Pascal, Philippe Metz, Florian A. Lempp, et al.. (2018). HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Gastroenterology. 154(6). 1791–1804.e22. 126 indexed citations

13.

Qu, Bingqian, Yi Ni, Florian A. Lempp, Florian W. R. Vondran, & Stephan Urban. (2018). T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR. Journal of Virology. 92(23). 39 indexed citations

14.

Bogomolov, Pavel, A. A. Alexandrov, Н. В. Воронкова, et al.. (2016). Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study. Journal of Hepatology. 65(3). 490–498. 275 indexed citations

15.

Lempp, Florian A., Yi Ni, & Stephan Urban. (2016). Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options. Nature Reviews Gastroenterology & Hepatology. 13(10). 580–589. 116 indexed citations

16.

Lempp, Florian A., Pascal Mutz, Christoph Lipps, et al.. (2015). Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor. Journal of Hepatology. 64(3). 556–564. 61 indexed citations

17.

Bogomolov, Pavel, Н. В. Воронкова, Lena Allweiss, et al.. (2014). a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20. Hepatology. 60(6). 24 indexed citations

18.

Lempp, Florian A. & Stephan Urban. (2014). Inhibitors of Hepatitis B Virus Attachment and Entry. Intervirology. 57(3-4). 151–157. 50 indexed citations

19.

Nkongolo, Shirin, Yi Ni, Florian A. Lempp, et al.. (2013). Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. Journal of Hepatology. 60(4). 723–731. 195 indexed citations

20.

Ni, Yi, Florian A. Lempp, Stefan Mehrle, et al.. (2013). Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes. Gastroenterology. 146(4). 1070–1083.e6. 602 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact